Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample.
about
Facts, values, and attention-deficit hyperactivity disorder (ADHD): an update on the controversiesAnalysis of suspected suicides using poison center dataA review of geographic variation and Geographic Information Systems (GIS) applications in prescription drug use researchIndividual and contextual determinants of regional variation in prescription drug use: an analysis of administrative data from British ColumbiaGender and injuries predict stimulant medication use.National trends in psychotropic medication use in young children: 1994-2009Incidence and prevalence of drug-treated attention deficit disorder among boys in the UKAssociation between unemployment rates and prescription drug utilization in the United States, 2007-2010.Adolescents' motivations to abuse prescription medications.Prescription, dispensation and marketing patterns of methylphenidate.Variation in prescription use and spending for lipid-lowering and diabetes medications in the Veterans Affairs Healthcare SystemPromoting productive interactions between parents and physicians in the treatment of children with attention-deficit/hyperactivity disorder.Geographic variation of chronic opioid use in fibromyalgia.Effect of extended-release dexmethylphenidate and mixed amphetamine salts on sleep: a double-blind, randomized, crossover study in youth with attention-deficit hyperactivity disorder.ENTRY IN THE ADHD DRUGS MARKET: WELFARE IMPACT OF GENERICS AND ME-TOO'SGeographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States.Medical use, illicit use and diversion of prescription stimulant medicationState infant/toddler program policies for eligibility and services provision for young children with autism.Medical and nonmedical use of prescription drugs among secondary school students.Role of pharmacy services in accountable care organizationsProblematic Peer Functioning in Girls with ADHD: A Systematic Literature ReviewCorrelates of methylphenidate use in Canadian children: a cross-sectional study.Impact of attention-deficit/hyperactivity disorder (ADHD) on prescription dug spending for children and adolescents: increasing relevance of health economic evidence.Medication deserts: survey of neighborhood disparities in availability of prescription medications.Stimulant medication use in children: a 12-year perspective.Second-generation antipsychotic use among stimulant-using children, by organization of medicaid mental health.Geographic variation and disparity in stimulant treatment of adults and children in the United States in 2008Relationship Between Attention-Deficit/Hyperactivity Disorder Care and Medication Continuity.A randomized trial examining the effects of aerobic physical activity on attention-deficit/hyperactivity disorder symptoms in young childrenVariations in Mental Health Diagnosis and Prescribing Across Pediatric Primary Care PracticesAn international perspective on pediatric psychopharmacology.Racial and ethnic differences in childhood asthma treatment in the United StatesVariations in Physician Attitudes Regarding ADHD and Their Association With Prescribing PracticesInterstate variations in psychotropic medication use among a national sample of children in the child welfare system.Stimulant and non-stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006-2009.Hispanic Residential Isolation, ADHD Diagnosis and Stimulant Treatment among Medicaid-Insured Youth.Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines - United States, 2012.Trends in Pharmacotherapy for Bladder Dysfunction Among Children in the United States, 2000 to 2013.Provider and Site-Level Determinants of Testosterone Prescribing in the Veterans Healthcare System.Cardiac autonomic dysfunction and arterial stiffness among children and adolescents with attention deficit hyperactivity disorder treated with stimulants.
P2860
Q21202070-F611FA73-A136-4E86-B8F4-06BD5F1801ADQ23921390-39A6F845-0D32-4604-8F4D-DFE9EAE8F56EQ27025307-87E82728-8A97-439F-BD46-4483C4D9F694Q28476648-5612C14C-40A6-4266-8E48-71EE6DA691EEQ33782851-3A7FB370-E33D-44BB-A4F7-C4685F234E2BQ33819699-D8807B90-A330-4DAA-B95C-8DB1A18452C4Q34098764-6D6BB1E7-1248-4F99-893E-F64BD518658BQ34495367-230176E5-AE8A-43A9-94C7-C11876D80832Q34586685-77211164-5EEF-4594-B8AA-6EF11D5FF47CQ34851862-3933D1DB-E482-4B72-B99C-CC0D6C045A2AQ34985689-12E8F6FF-7D2C-486B-9CCC-230D55EDA916Q35135055-513A1B0B-4B89-4E19-86A7-8D7DD0577717Q35136682-F5272BA1-A083-40B2-999A-DF21878B4627Q35185147-9D14A993-BAC5-4D32-B280-4534035177C3Q35215867-CC38E38E-0188-4D27-8743-C56F3CD2FD21Q35241065-660C3A9C-60C8-4592-A7C7-BEC0025C9BE5Q35568469-615DE90D-DC63-4959-AC62-815FC34EEFDEQ35574264-FAE72FA4-FD87-4E5B-90F2-B03AD40E6150Q35574646-227F817B-3BFC-4A6A-B06D-C25A4D0AE807Q35713127-850DFD1D-0840-4625-8A4C-D642DC299BDEQ36199669-336D0D2D-243C-46AB-A251-084D78A7B73AQ36402477-18F51C01-3983-4F99-A2AD-A027B461C3CAQ36409734-5B107F12-F843-4D82-B2C3-84409102F7A0Q36453587-7D34D809-616B-458C-B19E-931C85BD6663Q36543244-674447F9-DDEC-4BB5-BFBE-490B945C214BQ36591575-E660262B-D605-4B45-B635-B9351797EF88Q36649094-AC2FA680-F339-4B08-8F7E-64CDE356FAB1Q36731199-4ECC83FF-37A1-4B59-8EE1-05B81408EF7AQ36783589-354E31B4-CB2B-4C00-BF7B-72A4A3C4C9A7Q36838202-D5C5A637-D7B4-4B1C-BBA2-5A4B09F71AD4Q37127420-CF33F5EF-9528-49DA-9171-689A37270359Q37421727-9EFEBCD2-59A9-4251-8061-04741961A5D0Q37714495-E02358B7-3D8A-4F94-B4EB-380F1230B4C9Q37735535-A765F3EE-1520-4363-A952-5AA03A071EE3Q38430606-9F20363F-670E-4CD8-B0F6-316E1EA8620CQ38691348-11BD4B8E-EC4B-4AA4-AC79-E100824ACB93Q39204538-DA875F52-229F-4ECB-8B5D-3398C3A3E255Q39853460-82E472F1-F13B-4AE4-BA78-817152BDEA2CQ40040723-1A86E32E-62D2-47C9-A732-A9329E5E17E7Q40207017-490C2D08-8271-44AD-B192-54E0FE087636
P2860
Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Geographic variation in the pr ...... ommercially insured US sample.
@en
Geographic variation in the pr ...... ommercially insured US sample.
@nl
type
label
Geographic variation in the pr ...... ommercially insured US sample.
@en
Geographic variation in the pr ...... ommercially insured US sample.
@nl
prefLabel
Geographic variation in the pr ...... ommercially insured US sample.
@en
Geographic variation in the pr ...... ommercially insured US sample.
@nl
P2093
P356
P1433
P1476
Geographic variation in the pr ...... ommercially insured US sample.
@en
P2093
Brenda R Motheral
Doug Mager
Emily R Cox
Rochelle R Henderson
P304
P356
10.1542/PEDS.111.2.237
P407
P577
2003-02-01T00:00:00Z